European Monitoring Centre for Drugs and Drug Addiction, Europol. (2010) Europol–EMCDDA joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & Europol.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Europol EMCDDA Mephadrone report)
- Published Version
240kB | |
|
PDF (Europol EMCDDA Mephadrone report. Annex 1 Main information sources)
- Supplemental Material
186kB | |
|
PDF (Europol EMCDDA Mephadrone report. Annex 2 images)
- Supplemental Material
2MB | |
|
PDF (Europol EMCDDA Mephadrone report. Annex 3 online shops)
- Supplemental Material
176kB |
Europe has responded to rising concern over the use of the synthetic drug mephedrone by formally requesting a scientific investigation into the health and social risks of the substance. The decision was communicated to the EU drugs agency (EMCDDA) by the Council of the EU , in line with a legal procedure designed to respond to potentially threatening new psychoactive drugs in the EU.
B Substances > New (novel) psychoactive substances > Synthetic cathinones > Mephedrone
E Concepts in biomedical areas > Pharmacology and toxicology
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment
L Social psychology and related concepts > Legal availability or accessibility
VA Geographic area > Europe
Repository Staff Only: item control page